Dr. Scott PalmerM.D.
Internal Medicine
at Scott Palmer, MD — Chicago, IL
About
Dr. Scott Palmer, M.D., trained at some of Chicago's most respected institutions. He earned his undergraduate degree from the University of Michigan and his medical degree from Rush Medical College. He completed his internship, residency, and chief residency at Presbyterian St. Luke's Hospital in Chicago, now Rush University Medical Center. He earned the resident of the year award in all three years of his residency training.
Dr. Palmer is board-certified in Internal Medicine and spent twenty-one years in private internal medicine at Rush before transitioning to concierge practice in 2010. Consumer's Research Council of America. Since 2005, he has served as Medical Team Physician for both the Chicago Bulls and the Chicago White Sox. Beyond clinical practice, Dr. Palmer co-founded Synthonics in 2006, a biotechnology company built around metal-coordinated drug delivery technology. He chairs the Synthonics Scientific Advisory Board and serves as medical director of its drug development projects. His research interests span neurodegenerative disorders, antibiotic resistance, hypothyroid management, novel cannabinoids, and cancer immunotherapy. Synthonics published a successful Phase 1 FDA trial in the journal Thyroid in 2018 on Poly-Zinc-Liothyronine, a novel extended-release T3 compound he helped develop.
Education & Training
Undergraduate
University of Michigan
Medical School
Rush Medical College
Residency
Internal Medicine, Presbyterian St. Luke's Hospital (now Rush University Medical Center), Chicago, IL; Chief Residency also completed there
Additional Training
Presbyterian St. Luke's Hospital, Chicago (internship, residency, and chief residency — now Rush University Medical Center)
Certifications
Conditions Treated
Who is Dr. Palmer right for?
Dr. Palmer is a strong fit for adults who want a physician deeply invested in prevention and long-term wellness. Patients managing complex or chronic conditions, including hypothyroidism, Parkinson's disease, chronic pain, anxiety, and PTSD, benefit from his broad internal medicine expertise. His research background makes him especially well-suited for patients navigating neurodegenerative disorders or treatment-resistant conditions. Adults who value direct physician access and unhurried appointments will find his practice structure a natural match.
Similar Doctors Nearby
Dr. Katarzyna SkuraMD
Dr. Alex LickermanMD
metabolic disorders, chronic disease, anxiety +2 more
Dr. Angel RiveraDO
hormonal imbalances, weight concerns, metabolic health conditions +1 more
Frequently Asked Questions
Dr. Palmer specializes in internal medicine and preventive medicine. His clinical focus includes disease prevention, long-term wellness planning, and health maintenance. He approaches each patient by considering genetic, physical, and emotional factors together.
Yes, Dr. Palmer holds board certification in Internal Medicine. He earned his medical degree from Rush Medical College and completed his residency training at Presbyterian St. Luke's Hospital in Chicago, now Rush University Medical Center.
Dr. Palmer earned his undergraduate degree from the University of Michigan and his medical degree from Rush Medical College. He completed his internship, residency, and chief residency at Presbyterian St. Luke's Hospital in Chicago. His peers recognized him with the resident of the year award in all three years of residency.
Annual physical exams with Dr. Palmer run a minimum of sixty minutes. All other visits run thirty minutes. He also offers same-day or next-business-day appointments for any concern, including non-urgent ones.
Yes. When a patient requires hospitalization, Dr. Palmer serves as the attending physician directly. He does not hand patients off to a hospitalist, so his patients receive continuity of care throughout any hospital stay.
Yes. Since 2005, Dr. Palmer has served as Medical Team Physician for both the Chicago Bulls and the Chicago White Sox. He maintains his staff affiliation at Rush University Medical Center alongside his concierge practice.
Yes. Dr. Palmer co-founded Synthonics in 2006, a biotechnology company focused on metal-coordinated drug delivery technology. He chairs the Synthonics Scientific Advisory Board and directs its drug development projects. His research interests include neurodegenerative disorders, antibiotic resistance, hypothyroid management, novel cannabinoids, and cancer immunotherapy. Synthonics published a Phase 1 FDA trial on Poly-Zinc-Liothyronine in the journal Thyroid in 2018.
Dr. Palmer sees adult patients across a broad range of health needs. His practice suits patients who want a preventive, relationship-centered approach to primary care. He also works well with patients managing chronic or complex conditions who want consistent, direct access to their physician.
Doctor profile last updated April 3, 2026